» Articles » PMID: 26481204

Mitochondrial Replacement: Ethics and Identity

Overview
Journal Bioethics
Specialty Medical Ethics
Date 2015 Oct 21
PMID 26481204
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial replacement techniques (MRTs) have the potential to allow prospective parents who are at risk of passing on debilitating or even life-threatening mitochondrial disorders to have healthy children to whom they are genetically related. Ethical concerns have however been raised about these techniques. This article focuses on one aspect of the ethical debate, the question of whether there is any moral difference between the two types of MRT proposed: Pronuclear Transfer (PNT) and Maternal Spindle Transfer (MST). It examines how questions of identity impact on the ethical evaluation of each technique and argues that there is an important difference between the two. PNT, it is argued, is a form of therapy based on embryo modification while MST is, instead, an instance of selective reproduction. The article's main ethical conclusion is that, in some circumstances, there is a stronger obligation to use PNT than MST.

Citing Articles

The Two-Tier Problem.

Wilkinson D J Moral Philos. 2025; :1-28.

PMID: 40051828 PMC: 7617454. DOI: 10.1163/17455243-21050021.


An analysis of different concepts of "identity" in the heritable genome editing debate.

Liaw Y Med Health Care Philos. 2024; 27(1):121-131.

PMID: 38189908 PMC: 10904499. DOI: 10.1007/s11019-023-10189-1.


Gene Editing, Identity and Benefit.

Douglas T, Devolder K Philos Q. 2023; 72(2):305-325.

PMID: 36812016 PMC: 9915102. DOI: 10.1093/pq/pqab029.


Initial heritable genome editing: mapping a responsible pathway from basic research to the clinic.

Ranisch R, Trettenbach K, Arnason G Med Health Care Philos. 2022; 26(1):21-35.

PMID: 36414813 PMC: 9984515. DOI: 10.1007/s11019-022-10115-x.


Role of abnormal energy metabolism in the progression of chronic kidney disease and drug intervention.

Liu X, Du H, Sun Y, Shao L Ren Fail. 2022; 44(1):790-805.

PMID: 35535500 PMC: 9103584. DOI: 10.1080/0886022X.2022.2072743.


References
1.
Savulescu J . Procreative beneficence: why we should select the best children. Bioethics. 2002; 15(5-6):413-26. DOI: 10.1111/1467-8519.00251. View

2.
Sheldon S, Wilkinson S . Termination of pregnancy for reason of foetal disability: are there grounds for a special exception in law?. Med Law Rev. 2003; 9(2):85-109. DOI: 10.1093/medlaw/9.2.85. View

3.
Skoog Svanberg A, Lampic C, Bergh T, Lundkvist O . Characterization of potential oocyte donors in Sweden. Hum Reprod. 2003; 18(10):2205-15. DOI: 10.1093/humrep/deg398. View

4.
Bredenoord A, Pennings G, Smeets H, De Wert G . Dealing with uncertainties: ethics of prenatal diagnosis and preimplantation genetic diagnosis to prevent mitochondrial disorders. Hum Reprod Update. 2007; 14(1):83-94. DOI: 10.1093/humupd/dmm037. View

5.
Torjesen I . Fertility regulator tells clinics to treat egg and sperm donors better to boost numbers. BMJ. 2012; 344:e2594. DOI: 10.1136/bmj.e2594. View